News | January 31, 2011

Study Confirms Parental History of Heart Attack is a Risk Factor Worldwide

January 31, 2011 – Parental history of heart disease nearly doubles a person’s risk in all regions of the world, even after considering all other known risk factors of heart disease. The results come from a study published in the Feb. 1, 2011, issue of the Journal of the American College of Cardiology.

In other words, many unknown genetic and environmental factors running in families remain to be discovered and play an important part in determining one’s likelihood of developing heart disease.

The INTERHEART Study, a multinational, case-control study, examined whether the relationship between parental history of myocardial infarction (MI) – or heart attack – and MI risk is independent of known cardiovascular risks and a small number of genetic variants mostly related to risk factors.

“This study finds that parental history of myocardial infarction, a very easy-to-measure risk factor, approximately doubles your risk of future heart attack, regardless of all other risk factors, including ethnicity, gender and socioeconomic position,” said Clara Chow, MBBS, Ph.D., head cardiac program, The George Institute. Chow is lead author of the study. “If both parents have a history of heart disease, and especially if it occurred at a young age, then the risk increases.”

Chow and her team concluded that parental history is an important, consistent and global determinant of heart disease. Both maternal and paternal histories are associated with an increased risk, and the younger the incidence in the parent, the higher the risk. After making adjustments for a set of nine risk factors – both biological and behavioral (i.e., abnormal lipids, smoking, hypertension, diet, etc.) – it was determined that the overall association of parental history is an important indicator.

“While other studies have shown the relationship between parental history and risk, they have not established its independence from the extensive list of other potential explanatory factors as measured by the INTERHEART Study and not established it in other world regions or ethnic groups,” Chow said.

Because of this, and its very wide applicability, Chow believes that this will put to rest a number of criticisms that parental history is not that important if other risk factors are well-measured and of uncertain significance in different population groups.

For more information: http://cardiosource.org/ACC


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now